Marsh & McLennan Companies, Inc.
NYSE:MRSHInsurance - Brokers
-$2.87 today
- Market cap
- $98.03B
- Beta
- 0.61
- P/E (TTM)
- 19.9
- EPS (TTM)
- $8.11
- Dividend yield
- 2.23%
Volume 1.40M
Average 3.00M
MRSH Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Marsh & McLennan Companies, Inc.NYSE: MRSH
Other Income / Expenses · Q3 FY2026 · quarter ended Sep 2026
Other income / expenses remains negative
Q3 FY2026 other income / expenses was -$182M, compared with -$160M a year earlier. Trailing-twelve-month other income / expenses was -$715M.
Context
- Other income / expenses amounted to 2.5% of revenue in FY2025, up 1.2 pp from a year earlier.
- Other income / expenses grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near -$182M or moves back toward the trailing-twelve-month quarterly average of -$178.75M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- (684M) USD
- Year-over-year change
- -103.0%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (684M) | -103.0% |
| FY2024 | 2024-12-31 | (337M) | -31.6% |
| FY2023 | 2023-12-31 | (256M) | -29.3% |
| FY2022 | 2022-12-31 | (198M) | -90.4% |
| FY2021 | 2021-12-31 | (104M) | — |
Other Income / Expenses vs competitors
How MRSH compares with its peers on the latest reported figures
- MRSH's LTM Sep 2026 other income / expenses of -$715M is the lowest of the 7 companies compared; the peer median is -$277M.
- Its year-over-year change of -9.3% is the 3rd highest of 6, against a peer median of -28.3%.
- Other income / expenses amounts to 2.5% of revenue for MRSH, versus a peer median of 4.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $300M | +140.5% | — | 1.7% | |
| LTM Sep 2026 | -$190.74M | -50.5% | — | 10.3% | |
| LTM Jun 2026 | -$262M | +58.1% | — | 2.6% | |
| LTM Sep 2026 | -$292M | -135.5% | — | 4.2% | |
| LTM Jun 2026 | -$367.81M | — | — | 11.4% | |
| LTM Jun 2026 | -$699.7M | -28.3% | — | 4.4% | |
| LTM Sep 2026 | -$715M | -9.3% | — | 2.5% | |
| Peer median (excluding MRSH) | -$277M | -28.3% | — | 4.3% | |
Competitors are the stored peer set for MRSH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 19.82B | 20.72B | 22.74B | 24.46B | 26.98B |
| Cost of Revenue | 11.43B | 12.07B | 13.1B | 14B | 15.58B |
| Gross Profit | 8.4B | 8.65B | 9.64B | 10.46B | 11.4B |
| Gross Margin | 42.4% | 41.7% | 42.4% | 42.8% | 42.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 4.08B | 4.37B | 4.36B | 4.65B | 5.18B |
| Depreciation & Amortization | 747M | 719M | 713M | 746M | 910M |
| EBITDA | 5.4B | 5.27B | 6.32B | 6.93B | 7.4B |
| EBITDA Margin | 27.2% | 25.4% | 27.8% | 28.3% | 27.4% |
| Operating Income | 4.31B | 4.28B | 5.28B | 5.82B | 6.22B |
| Operating Margin | 21.8% | 20.7% | 23.2% | 23.8% | 23.1% |
| Interest Income | 2M | 15M | 78M | 83M | 48M |
| Interest Expense | 444M | 469M | 578M | 700M | 960M |
| Other Income / Expenses | (104M) | (198M) | (256M) | (337M) | (684M) |
| Income Before Tax | 4.21B | 4.08B | 5.03B | 5.48B | 5.54B |
| Pre-Tax Margin | 21.2% | 19.7% | 22.1% | 22.4% | 20.5% |
| Income Tax Expense | 1.03B | 995M | 1.22B | 1.36B | 1.31B |
| Net Income | 3.14B | 3.05B | 3.76B | 4.06B | 4.16B |
| Net Margin | 15.9% | 14.7% | 16.5% | 16.6% | 15.4% |
| EPS (Basic) | 6.20 | 6.11 | 7.60 | 8.25 | 8.48 |
| EPS (Diluted) | 6.13 | 6.04 | 7.53 | 8.18 | 8.43 |
| Weighted Avg Shares | 507M | 499M | 494M | 492M | 487M |
| Weighted Avg Shares (Diluted) | 513M | 505M | 499M | 496M | 490M |
Marsh & McLennan Companies, Inc.
NYSE:MRSH
Intrinsic Alpha fair value
Locked
Current Price
$205.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.